Hackensack University Medical Center is providing some patients with a new approach to treating pre-malignant tumors in the pancreas. HackensackUMC is the first hospital in New Jersey to offer endoscopic ultrasound (EUS)-guided focal radio frequency ablation (RFA) in the pancreas.
RFA uses high-frequency alternating electrical current to ablate diseased tissue and has been used to treat various tumors. Equipped with the Emcision Habib RFA device, which received full approval from the Food and Drug Administration earlier this year, HackensackUMC physicians can now ablate small lesions in the pancreas safely and accurately.
“Although the technology is new, targeted RFA in the pancreas is extremely promising and offers hope as a non-surgical option to treat carefully-selected patients,” says Rosario Ligresti, M.D., FASGE, chief, Division of Gastroenterology and director of the Pancreas Center at HackensackUMC.
For now, this approach will concentrate solely on the ablation of pre-malignant cysts and solid tumors in the pancreas that are smaller than two centimeters.
“We take any opportunity to nip pancreatic cancer in the bud,” said Dr. Ligresti. “This is an outpatient procedure that is low stress and potentially highly effective.”
November is Pancreatic Cancer Awareness Month. Looking ahead, HackensackUMC together with the National Pancreas Foundation (NPF) will sponsor a fundraising dinner with live entertainment in January. Details will follow.
HackensackUMC is one of only 30 designated National Pancreas Foundation Centers of Excellence in the nation. NPF Centers are at premier healthcare facilities nationwide that focus on multidisciplinary treatment of pancreatic disease, treating the whole patient with a focus on the best possible outcomes and an improved quality of life.
For more information about this and our many other efforts to fight this deadly disease, please contact Dr. Ligresti at 201-488-3003.
About Hackensack University Medical Center
HackensackUMC, a 775- bed nonprofit teaching and research hospital located in Bergen County, NJ, is the largest provider of inpatient and outpatient services in the state. Founded in 1888 as the county’s first hospital, it is the flagship hospital of Hackensack University Health Network, one of the largest health networks in the state comprised of 1,717 beds, more than 10,000 team members and 3,300 credentialed physicians. HackensackUMC was listed as the number one hospital in New Jersey in U.S. News & World Report’s 2015-16 Best Hospital rankings - maintaining its place atop the NJ rankings since the rating system was introduced. It was also named one of the top four New York Metro Area hospitals. HackensackUMC is the only hospital in New Jersey, New York and New England to be named one of Healthgrades America's 50 Best Hospitals™ nine consecutive years, and receive the Healthgrades Distinguished Hospital Award for Clinical Excellence™ 13 years in a row. The medical center is one of the top 25 green hospitals in the country according to Practice Greenhealth, and received 24 Gold Seals of Approval™ by The Joint Commission – more than any other hospital in the country. It was the first hospital in New Jersey and second in the nation to become a Magnet® recognized hospital for nursing excellence; receiving its fifth consecutive designation in 2014. HackensackUMC has created an entire campus of award-winning care, including: the John Theurer Cancer Center; the Heart & Vascular Hospital; and the Sarkis and Siran Gabrellian Women’s and Children’s Pavilion, which houses the Joseph M. Sanzari Children’s Hospital and Donna A. Sanzari Women’s Hospital, which was designed with The Deirdre Imus Environmental Health Center and listed on the Green Guide’s list of Top 10 Green Hospitals in the U.S. HackensackUMC is the Hometown Hospital of the New York Giants and the New York Red Bulls and is Official Medical Services Provider to The Barclays PGA Golf Tournament. It remains committed to its community through fundraising and community events. To learn more, visit: www.HackensackUMC.org.